PUBLISHER: Allied Market Research | PRODUCT CODE: 1193105
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193105
The global respiratory masks market was valued at $527.1 million in 2021, and is projected to reach $2,394.3 million by 2031, registering a CAGR of 16.4% from 2022 to 2031. A respiratory mask is a piece of equipment made to prevent the user from breathing potentially harmful atmospheres, such as dust, vapor, gas, and particle matter. A mask is defined as a device which is worn over the mouth and nose to protect the respiratory system by filtering out dangerous substances (such as dusts, fumes, or bacteria) from inhaled air. Particulate respirator masks can only filter out particles; they are ineffective against gases or vapors. Such a respirator may be given a numerical rating, like 95 or 99 to represent the amounts of airborne particles filtered. In addition, a letter may be used to designate if something is relatively resistant (R), not resistant (NR), or substantially resistant (P) to the effects of oil on proper respirator operation.
The respiratory mask market is driven by rise in prevalence of COVID-19 and increase in the prevalence of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and obstructive sleep apnea (OSA). For instance, according to the World Health Organization (WHO), in September 2022, confirmed cases of COVID-19 are 600,555,262 including 6,472,914 deaths. Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus experience mild to moderate respiratory illness. As COVID-19 is spread through air, there is rise in demand for respiratory mask for prevention purpose. Hence, rise in the prevalence of COVID-19 disease is anticipated to fuel the growth of the respiratory mask market. Moreover, adverse climate conditions and air pollution are the major causes that increase the prevalence rate of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and obstructive sleep apnea (OSA), which, in turn, boost the demand for respiratory masks, thereby augmenting the market growth. For instance, according to the World Cancer Research Fund International, in 2020, around 2,206,771 new lung cancer cases were diagnosed globally. Among them, 1,435,943 male and 770,828 female population got affected. Moreover, rising air pollution in environment and rise in the awareness among the people regarding the effectiveness of respiratory masks are anticipated to fuel the market growth.
In addition, governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. healthcare spending grew by 9.7% from 2019 to 2020, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in UK accounted for 12.8% of the gross domestic product (GDP) in 2020, as compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and material used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for respiratory mask application for prevention purpose, thereby boosting the market growth.
On the other hand, fluctuation in prices of protective face masks and production of non-biodegradable masks are some factors that are anticipated to restrain the growth of the respiratory mask market.
The respiratory mask market is segmented on the basis of type, age group, end user, and region. On the basis of type, market is segmented into disposable and reusable. The disposable mask segment is sub-categorized into N series, P series, and R series. On the basis of age group, the market is divided into neonatal and pediatric, adults, and geriatric. On the basis of end user, the market is divided into hospitals, nursing homes and clinics, trauma centers, and homecare. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global respiratory mask market include, 3M, AlphaProTech, ANSELL LTD, Cardinal Health, Delta Plus Group, Honeywell International Inc., KOKEN LTD., Macopharma., McKesson Corporation, Medline Industries, Inc., Moldex-Metric, Owens & Minor, RSG Safety, and Zelinsky Group Ltd.
Key Benefits For Stakeholders
By End User
By Type
By Age Group
By Region